CA2391274C — Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
Assigned to Kaken Pharmaceutical Co Ltd · Expires 2010-12-14 · 15y expired
What this patent protects
A novel method for evaluating an effect of an antimicrobial agent which comprises removing the antimicrobial agent remaining in a biological sample infected with a pathogenic microorganism or the like by removing the antimicrobial agent and thereafter detecting the viable pathoge…
USPTO Abstract
A novel method for evaluating an effect of an antimicrobial agent which comprises removing the antimicrobial agent remaining in a biological sample infected with a pathogenic microorganism or the like by removing the antimicrobial agent and thereafter detecting the viable pathogenic microorganism in the biological sample or infected site to thereby accurately evaluate the effect of the antimicrobial agent on the pathogenic microorganism without being effected by the remaining antimicrobial agent. The novel method also provides a screening method for therapeutic agents effective for detecting pathogenic microorganisms, for treating fungal infections, in particular, onychomycosis.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.